🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
23/03/2016 4,79 4,99 4,39 4,40 -8,71% 12,53% 548.000
22/03/2016 4,44 4,89 4,35 4,82 +7,11% 12,16% 455.600
21/03/2016 4,48 4,68 4,32 4,50 -0,66% 8,04% 436.700
18/03/2016 4,31 4,53 4,12 4,53 +7,60% 9,51% 854.000
17/03/2016 4,20 4,28 4,04 4,21 +0,00% 5,71% 451.000
16/03/2016 4,19 4,29 4,10 4,21 -0,24% 4,53% 345.000
15/03/2016 4,35 4,51 4,17 4,22 -6,43% 7,82% 694.400
14/03/2016 4,46 4,68 4,44 4,51 +0,45% 5,38% 387.600
11/03/2016 4,59 4,59 4,25 4,49 +3,22% 7,41% 371.700
10/03/2016 4,45 4,59 4,25 4,35 -2,90% 7,64% 486.200
09/03/2016 4,66 4,75 4,39 4,48 -2,40% 7,62% 570.700
08/03/2016 4,78 4,95 4,55 4,59 -3,57% 8,37% 914.400
07/03/2016 4,32 5,00 4,29 4,76 +9,93% 16,41% 865.300
04/03/2016 4,20 4,55 4,16 4,33 +2,12% 9,17% 582.600
03/03/2016 4,38 4,50 4,19 4,24 -4,29% 7,08% 817.000
02/03/2016 4,14 4,48 4,10 4,43 +7,00% 9,18% 735.000
01/03/2016 3,90 4,14 3,87 4,14 +6,15% 7,03% 640.100
29/02/2016 3,96 4,10 3,87 3,90 -1,76% 5,81% 547.700
26/02/2016 3,89 3,97 3,84 3,97 +2,85% 3,34% 386.600
25/02/2016 3,86 3,91 3,72 3,86 +0,78% 4,92% 446.700
24/02/2016 3,87 3,87 3,57 3,83 -1,29% 7,75% 565.700
23/02/2016 4,09 4,17 3,86 3,88 -5,13% 7,58% 533.100
22/02/2016 3,98 4,17 3,95 4,09 +3,81% 5,45% 643.500
19/02/2016 3,81 4,01 3,70 3,94 +4,23% 8,01% 703.800
18/02/2016 3,92 3,98 3,74 3,78 -4,06% 6,20% 723.000
17/02/2016 3,60 3,96 3,58 3,94 +10,67% 10,56% 765.000
16/02/2016 3,40 3,64 3,40 3,56 +5,95% 7,06% 748.300
12/02/2016 3,32 3,39 3,22 3,36 +1,82% 5,12% 599.000
11/02/2016 3,14 3,36 3,07 3,30 +2,80% 9,24% 885.500
10/02/2016 3,40 3,62 3,20 3,21 +0,94% 12,35% 943.500